Reset filter
Palavras-chave
Involutionsdepression ×
Mostrar mais Palavras-chave
Índice
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
    1. 7.1. Anästhesie
    1. 7.2. Dermatologie
    1. 7.3. HNO
    1. 7.4. Geriatrie
    1. 7.5. Gynäkologie/Geburtshilfe
    1. 7.6. Innere Medizin
      1. Hämatologie
      1. Infektiologie
      1. Kardiologie/Angiologie
      1. Pneumologie
      1. Gastroenterologie
      1. Nephrologie
      1. Endokrinologie/Stoffwechsel
      1. Rheumatologie
    1. 7.7. Neurologie
    1. 7.8. Augenheilkunde
    1. 7.9. Palliativmedizin
    1. 7.10. Pathologie/Rechtsmedizin
    1. 7.11. Kinderheilkunde
    1. 7.12. Psychiatrie/Psychosomatik
    1. 7.13. Radiologie
    1. 7.14. Chirurgie
      1. Allgemein-/Viszeralchirurgie
      1. Neurochirurgie
      1. Plastische Chirurgie
      1. Herz-/Thoraxchirurgie
      1. Unfallchirurgie/Orthopädie
      1. Gefäßchirurgie
    1. 7.15. Urologie
    1. 7.16. Zahnmedizin/MKG
Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

215 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Eligibility Major Depression NCT00531895

- 29.04.17 - 1 Formulário, 2 Grupos de itens, 13 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache; ODM derived from: https://clinicaltrials.gov/show/NCT00531895

DELCODE: DZNE – Longitudinal Cognitive Impairment and Dementia Study - Major Depression Episode (MDE) Baseline (Major Depression Episode (MDE) Baseline)

- 09.04.20 - 1 Formulário, 4 Grupos de itens, 26 Elementos de dados, 1 Idioma
Grupos de itens: Administrative Data, Major Depression Episode (MDE), Major Depression Episode (MDE) lifetime, MDE - Lifetime
DELCODE is conducted by DZNE, the German Center for Neurodegenerative Diseases within the Helmholtz Association. The following information was taken from https://www.dzne.de/en/research/studies/clinical-studies/delcode/. Background and aims: One of the important aims of research into Alzheimer's is to find ways of detecting the disease early – if at all possible, as soon as the first minor symptoms appear, or even before any symptoms at all have appeared. Such detection capabilities are the necessary basis for development of therapies that can be applied at such early stages in the disease. Recent research indicates that such therapies could be more effective than therapies initiated during the disease's later stages. Over a period of several years, the DELCODE study is studying persons in early stages of the disease, along with various risk groups. The research is aimed at the development of procedures for characterizing early stages of the disease, at improving prediction of the course of the disease and at identifying new markers for early diagnosis of Alzheimer's-related dementia. Overview: DELCODE is set up to run for an initial period of three years, and to include a total of 1,000 study participants, who will be examined on a yearly basis. The group of participants will include persons with no complaints (healthy control subjects), patients with slight memory impairment or mild dementia and first-degree relatives of patients with diagnosed Alzheimer's disease. The minimum age for participants is 60. Course of the study: The examinations in the framework of the study will include a comprehensive interview carried out by a study investigator, a detailed neuropsychological examination (testing of memory functions and other areas of cognitive performance), a blood test and a cranial MRI scan. Optionally, subject to the study participant's consent in each case, a lumbar puncture (collection of cerebrospinal fluid) will be carried out." For more information (e.g. principle investigator and study coordination), please visit the above link or https://www.dzne.de. This document contains the Major Depression Episode (MDE) Baseline form. It has to be filled in for Baseline. For use of this questionnaire no licence is required.

DELCODE: DZNE – Longitudinal Cognitive Impairment and Dementia Study - Major Depression Episode (MDE) Follow-up (Major Depression Episode (MDE) Follow-up)

- 09.04.20 - 1 Formulário, 3 Grupos de itens, 23 Elementos de dados, 1 Idioma
Grupos de itens: Administrative Data, Major Depression Episode (MDE), Major Depression Episode (MDE) since last visit
DELCODE is conducted by DZNE, the German Center for Neurodegenerative Diseases within the Helmholtz Association. The following information was taken from https://www.dzne.de/en/research/studies/clinical-studies/delcode/. Background and aims: One of the important aims of research into Alzheimer's is to find ways of detecting the disease early – if at all possible, as soon as the first minor symptoms appear, or even before any symptoms at all have appeared. Such detection capabilities are the necessary basis for development of therapies that can be applied at such early stages in the disease. Recent research indicates that such therapies could be more effective than therapies initiated during the disease's later stages. Over a period of several years, the DELCODE study is studying persons in early stages of the disease, along with various risk groups. The research is aimed at the development of procedures for characterizing early stages of the disease, at improving prediction of the course of the disease and at identifying new markers for early diagnosis of Alzheimer's-related dementia. Overview: DELCODE is set up to run for an initial period of three years, and to include a total of 1,000 study participants, who will be examined on a yearly basis. The group of participants will include persons with no complaints (healthy control subjects), patients with slight memory impairment or mild dementia and first-degree relatives of patients with diagnosed Alzheimer's disease. The minimum age for participants is 60. Course of the study: The examinations in the framework of the study will include a comprehensive interview carried out by a study investigator, a detailed neuropsychological examination (testing of memory functions and other areas of cognitive performance), a blood test and a cranial MRI scan. Optionally, subject to the study participant's consent in each case, a lumbar puncture (collection of cerebrospinal fluid) will be carried out." For more information (e.g. principle investigator and study coordination), please visit the above link or https://www.dzne.de. This document contains the Major Depression Episode (MDE) Follow-up form. It has to be filled in for follow-up visits. For use of this questionnaire no licence is required.

Eligibility Major Depression NCT00343070

- 05.06.18 - 1 Formulário, 2 Grupos de itens, 16 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Functional Neuroimaging in Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00343070

Eligibility Major Depression NCT01244724

- 20.09.21 - 1 Formulário, 2 Grupos de itens, 19 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Lexapro for Major Depression in Patients With Epilepsy; ODM derived from: https://clinicaltrials.gov/show/NCT01244724

Eligibility Major Depression NCT02434393

- 03.05.19 - 1 Formulário, 2 Grupos de itens, 29 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project; ODM derived from: https://clinicaltrials.gov/show/NCT02434393

Eligibility Major Depression NCT02047968

- 03.05.19 - 1 Formulário, 2 Grupos de itens, 13 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Wake and Light Therapy to In-patients With Major Depression: Efficacy, Predictors and Patient Experiences; ODM derived from: https://clinicaltrials.gov/show/NCT02047968

Eligibility Major Depression NCT02441387

- 05.01.19 - 1 Formulário, 2 Grupos de itens, 9 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Predictors of the Outcome of Late Life Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02441387

Eligibility Major Depression NCT01792414

- 05.01.19 - 1 Formulário, 2 Grupos de itens, 9 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Transcranial Electrical Stimulation (TES) for the Treatment of Depression.; ODM derived from: https://clinicaltrials.gov/show/NCT01792414

Eligibility Major Depression NCT01492621

- 05.01.19 - 1 Formulário, 2 Grupos de itens, 9 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Effect of Antidepressants on White Matter Structure; ODM derived from: https://clinicaltrials.gov/show/NCT01492621

Eligibility Major Depression NCT01153139

- 05.01.19 - 1 Formulário, 2 Grupos de itens, 11 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Long-term Bilateral Theta Burst Stimulation for the Treatment of Major Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01153139

Eligibility Major Depression NCT00825799

- 05.06.18 - 1 Formulário, 2 Grupos de itens, 14 Elementos de dados, 1 Idioma
Grupos de itens: Criteria, Exclusion Criteria
Serum Markers as a Bioassay for Unipolar Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00825799

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial